Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$224.58 - $256.19 $5.13 Million - $5.86 Million
-22,859 Reduced 94.8%
1,253 $312,000
Q4 2023

Feb 02, 2024

SELL
$185.1 - $233.13 $377,233 - $475,118
-2,038 Reduced 7.79%
24,112 $5.58 Million
Q3 2023

Nov 01, 2023

BUY
$233.08 - $265.59 $1.76 Million - $2.01 Million
7,557 Added 40.64%
26,150 $6.49 Million
Q2 2023

Aug 04, 2023

BUY
$224.99 - $256.14 $4.18 Million - $4.76 Million
18,593 New
18,593 $4.46 Million
Q3 2022

Nov 04, 2022

BUY
$247.06 - $1507.4 $2.76 Million - $16.8 Million
11,167 New
11,167 $2.88 Million
Q2 2022

Aug 03, 2022

SELL
$237.11 - $299.66 $3.69 Million - $4.67 Million
-15,582 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$257.27 - $315.76 $2.43 Million - $2.98 Million
9,452 Added 154.19%
15,582 $4.57 Million
Q4 2021

Feb 23, 2022

BUY
$292.08 - $329.01 $1.79 Million - $2.02 Million
6,130 New
6,130 $2.02 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $298,231 - $359,989
-1,325 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$212.38 - $245.9 $2.28 Million - $2.64 Million
-10,718 Reduced 89.0%
1,325 $298,000
Q4 2020

Feb 02, 2021

BUY
$212.5 - $245.46 $2.27 Million - $2.62 Million
10,675 Added 780.34%
12,043 $2.68 Million
Q3 2020

Oct 14, 2020

BUY
$177.16 - $215.33 $242,354 - $294,571
1,368 New
1,368 $294,000
Q2 2020

Jul 13, 2020

SELL
$128.7 - $176.83 $57,528 - $79,043
-447 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$121.39 - $169.05 $269,121 - $374,783
-2,217 Reduced 83.22%
447 $61,000
Q4 2019

Feb 05, 2020

BUY
$133.47 - $153.48 $355,564 - $408,870
2,664 New
2,664 $408,000
Q3 2018

Oct 23, 2018

SELL
$98.13 - $108.9 $890,529 - $988,267
-9,075 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$96.1 - $103.24 $872,107 - $936,903
9,075 New
9,075 $895,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.